![]() |
市場調查報告書
商品編碼
1492526
截肢後慢性疼痛管理市場:按類型、治療類型、最終用戶分類 - 全球預測 2024-2030Chronic Post-Amputation Pain Management Market by Type (Neuroma Pain, Phantom Limb Pain, Stump Pain), Treatment Type (Medication, Neuromodulation Techniques, Surgical Interventions), End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
截肢後慢性疼痛管理市場規模預計到 2023 年為 56.5 億美元,2024 年達到 59.6 億美元,2030 年達到 83.1 億美元,預計複合年成長率為 5.66%。
慢性截肢後疼痛是指一些人在肢體或部分肢體截肢後所經歷的持續性疼痛。這種類型的疼痛可以有多種形式,包括幻肢痛(在缺失的肢體中感覺到疼痛)和殘肢疼痛(在截肢的殘肢中感覺到疼痛)。由此產生的不適可能是中度至重度,使日常生活變得困難,並可能導致情緒和心理困擾。這種疼痛管理需要結合藥物治療、物理治療,有時還需要心理諮詢,以解決截肢對身體和心理的影響。主要由於糖尿病、血管疾病和創傷導致的截肢數量不斷增加,導致對有效的截肢後疼痛管理解決方案的需求不斷成長。許多地區支持醫療保健服務的政府政策和報銷框架涵蓋了慢性疼痛管理治療,使患者更容易獲得治療,並進一步支持市場擴張。然而,與用於治療慢性截肢後疼痛的醫療產品的開發和處置相關的環境問題正在阻礙市場成長。脊髓刺激和周邊神經刺激等神經調節技術可以幫助控制截肢後的慢性疼痛。研究和開發侵入性較小且更易於使用的更複雜的神經調節設備為截肢後慢性疼痛管理市場的成長提供了重大機會。
主要市場統計 | |
---|---|
基準年[2023] | 56.5億美元 |
預測年份 [2024] | 59.6億美元 |
預測年份 [2030] | 83.1億美元 |
複合年成長率(%) | 5.66% |
區域洞察
在美洲,特別是在美國和加拿大,人們非常關注先進的藥物治療和技術主導的解決方案來管理慢性截肢後疼痛。此外,在疼痛訊號到達大腦之前對其進行調節的神經調節劑的使用以及義肢對準和組裝服務越來越注重減少因義肢適配不良引起的不適。在亞太地區,由於醫療保健成本不斷上升、人們對疼痛管理解決方案的認知不斷提高以及醫療保健基礎設施的改善,用於治療全關節重建術後慢性疼痛的截肢後慢性疼痛管理市場正在不斷發展。日本和澳洲等國家擁有先進的醫療設施,並願意採用新技術和治療方法。在歐洲、中東和非洲地區,特別是歐洲,先進的醫療設備和強大的法律規範支持截肢後疼痛管理的綜合方法。中東國家,特別是沙烏地阿拉伯和阿拉伯聯合大公國等海灣國家,正在迅速發展醫療基礎設施,並增加獲得最新疼痛管理療法的機會。在非洲,人們逐漸意識到需要更好的疼痛管理策略,醫療保健服務也逐漸改善。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在慢性截肢後疼痛管理市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對慢性截肢後疼痛管理市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對截肢後慢性疼痛管理市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[180 Pages Report] The Chronic Post-Amputation Pain Management Market size was estimated at USD 5.65 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 5.66% to reach USD 8.31 billion by 2030.
Chronic post-amputation pain refers to the ongoing pain that some individuals experience after having a limb or part of a limb amputated. This type of pain manifests in various forms, including phantom limb pain, where the person feels pain in the part of the limb that is no longer there, and residual limb pain, which is pain in the stump of the amputated limb. The arising discomfort can be moderate to severe and might affect the individual's quality of life, making it difficult to perform daily activities and potentially leading to emotional or psychological distress. Managing this pain requires a combination of medical treatments, physical therapy, and sometimes psychological counseling to address the physical and emotional effects of amputation. A rise in the number of amputations primarily due to diabetes, vascular diseases, and traumatic injuries contributes to a greater demand for effective post-amputation pain management solutions. Government policies supporting healthcare services and reimbursement frameworks in many regions cover treatments for chronic pain management, making treatments more accessible to patients and further propelling market expansion. However, environmental concerns associated with developing and disposing of medical products for managing chronic post-amputation pain hinder market growth. Neuromodulation techniques, such as spinal cord and peripheral nerve stimulation, help manage chronic post-amputation pain. The research and development in more sophisticated neuromodulation devices that are less invasive and more user-friendly offer significant opportunities for chronic post-amputation pain management market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.65 billion |
Estimated Year [2024] | USD 5.96 billion |
Forecast Year [2030] | USD 8.31 billion |
CAGR (%) | 5.66% |
Regional Insights
In the Americas, particularly in the United States and Canada, there is a strong focus on advanced medicinal treatments and technology-driven solutions for managing chronic post-amputation pain. In addition, there is a growing emphasis on using neuromodulation devices, which help modulate pain signals before they reach the brain, and prosthetic alignment and fitting services reduce the discomfort caused by poorly fitted prostheses. In the Asia-Pacific region, the chronic post-amputation pain management market for managing chronic post-amputation pain is evolving, driven by increasing healthcare expenditure, growing awareness about pain management solutions, and an improved healthcare infrastructure. Countries, including Japan and Australia, feature advanced medical facilities and readily adopt new technologies and treatments. In the EMEA region, particularly In Europe, the availability of advanced healthcare facilities and a strong regulatory framework support a comprehensive approach to post-amputation pain management. Middle Eastern countries, particularly Gulf states such as Saudi Arabia and the UAE, are rapidly improving their healthcare infrastructure and have increasing access to modern pain management therapies. In Africa, there is an increasing recognition of the need for better pain management strategies, leading to gradual improvements in healthcare offerings.
Market Insights
The market dynamics represent an ever-changing landscape of the Chronic Post-Amputation Pain Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Chronic Post-Amputation Pain Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Chronic Post-Amputation Pain Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
Trinity Capital Inc. committed a USD 25 million investment to Neuros Medical, Inc. This infusion of capital aims to advance Neuros Medical's innovative bioelectric technology, which is dedicated to reducing chronic pain for individuals who have undergone amputations, improving their quality of life. [Published On: 2023-10-31]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Chronic Post-Amputation Pain Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.
Market Segmentation & Coverage